Evidence for impaired endothelium dependent vasodilation in experimental left ventricular dysfunction

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Experimental Medicine

Background:

• Adriamycin (doxorubicin) is a chemotherapy agent known to cause cardiotoxicity.
• Left ventricular dysfunction can lead to systemic circulatory alterations.
• Vascular reactivity is crucial for maintaining adequate blood flow and tissue perfusion.

Purpose of the Study:

• To investigate the impact of adriamycin-induced cardiomyopathy on hindlimb vascular reactivity in conscious rabbits.
• To assess the range and sensitivity of vasodilator and constrictor responses under autonomic blockade.
• To determine if left ventricular dysfunction affects endothelium-dependent vasodilation.

Main Methods:

• Experimental induction of cardiomyopathy using adriamycin in rabbits.
• Assessment of left ventricular systolic function via echocardiography.
• Pharmacological autonomic effector block.
• Measurement of hindlimb vascular resistance responses to acetylcholine, adenosine, noradrenaline, and angiotensin II.

Main Results:

• Adriamycin treatment significantly reduced left ventricular fractional shortening, confirming systolic dysfunction.
• The range of vasodilator responses to acetylcholine and adenosine was significantly attenuated (41% and 37%, respectively).
• The sensitivity (ED50) for both vasodilator and constrictor responses remained unaltered, with a non-significant attenuation in constrictor response range.

Conclusions:

• Experimental cardiomyopathy induced by adriamycin leads to an attenuated capacity for endothelium-dependent vasodilation in the hindlimb circulation.
• While the range of vascular responses is affected, the sensitivity to vasodilators and constrictors is preserved in this model.
• These findings suggest impaired regional blood flow regulation in the context of adriamycin-induced left ventricular dysfunction.